K Number
K041242
Device Name
CANDELA SMOOTHBEAM LASER SYSTEM
Manufacturer
Date Cleared
2004-11-22

(195 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Candela Smoothbeam Laser is indicated for the following uses: For use in dermatology: incision, excision, ablation, and vaporization with hemostasis of soft tissue, Treatment of back acne, Treatment of atrophic acne scars, Treatment of facial wrinkles, Treatment of mild to moderate acne vulgaris, New indication: Treatment of Sebaceous Hyperplasia
Device Description
The Diode laser is a Continuous Wave, diode medical laser, controlled by an embedded processor, to be used in dermatology for the treatment of wrinkles. The Candela Smoothbeam Laser System is comprised of a power supply, optical delivery system, software control system and Dynamic Cooling Device. The laser output produces circular beams on the skin. The Dynamic Cooling Device, provides a short burst of cryogen spray during the laser treatment. The cryogen is delivered via a hose to a nozzle located in the handpiece. The Dynamic Cooling Device functions to cool the skin during the laser treatment, minimizing thermal damage to skin during laser treatment and reducing pain associated with laser treatment. The Candela Smoothbeam Laser System is equipped with safety interlock systems to protect patients and operations. Users of the device, make selections from a control panel to regulate operation during the laser treatment.
More Information

Not Found

No
The description focuses on the laser technology, cooling system, and embedded processor for control, with no mention of AI or ML capabilities.

Yes.
The device is used for treatment of various skin conditions and for incision, excision, ablation, and vaporization with hemostasis of soft tissue.

No

This device is described as a laser system for treatment purposes (incision, excision, ablation, vaporization, treatment of acne, wrinkles, sebaceous hyperplasia), not for diagnosing conditions.

No

The device description explicitly states it is a "Diode laser" and includes physical components like a "power supply, optical delivery system, software control system and Dynamic Cooling Device." This indicates it is a hardware device with integrated software, not a software-only medical device.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. These tests are performed outside of the living body (in vitro).
  • Device Description and Intended Use: The Candela Smoothbeam Laser is a laser system used for direct treatment of the skin (soft tissue). It performs procedures like incision, excision, ablation, vaporization, and treats conditions like acne, acne scars, wrinkles, and sebaceous hyperplasia. These are all procedures performed on the patient's body, not on samples taken from the body.

The device's function and intended use clearly fall under the category of a therapeutic or surgical device, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The Candela Smoothbeam Laser is indicated for the following uses : For use in dermatology: incision, excision, ablation, and vaporization with hemostasis of soft tissue, Treatment of back acne Treatment of atrophic acne scars Treatment of facial wrinkles Treatment of mild to moderate acne vulgaris New indication : Treatment of Sebaceous Hyperplasia

Product codes

GEX

Device Description

The Diode laser is a Continuous Wave, diode medical laser, controlled by an embedded processor, to be used for applications such as the coagulation of soft tissue where remodeling of wrinkles. The Candela Smoothbeam Laser System is comprised of a power supply, optical delivery system, software control system and Dynamic Cooling Device. The laser output power supply, optical defreery of claring cosmation of the produces circular beams on the skin. The Dynamic Clooling Device, provides a short burst of cryogen spray during the laser treatment. The cryogen is delivered via a hose to a nozzle located in the handpiece. The Dynamic Cooling Device functions to cool the skin during the a hose to a nozine risunizing thermal damage to skin during laser treatment and reducing pain associated with laser treatment.

The Candela Smoothbeam Laser System is equipped with safety interlock systems to protect patients and operations. IJsers of the device, make selections from a control panel to regulate operation during the laser treatment.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The modality of action for the treatment of sebaceous hyperplasia is similar to that of previously cleared indications in the treatment of back acne and the treatment of inflammatory acne vulgaris. Published clinical data, using t he predicate Smoothbeam Laser, cleared for use in the market, produced results that demonstrate that the Smoothbeam Laser is safe and effective for the expanded indication, - the treatment of sebaceous hyperplasia

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K013825, K030834

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

K041242

NOV 2 2 2004

General Information:

This 510(k) is to provide notification of substantial equivalence for the Candela Smoothbeam Laser System, I mis 10(x) is to provide notheaton of succements veal notended for use in the treatment of facial acne

| Submitted by: | Candela Corporation
530 Boston Post Road
Wayland, MA 01778-1886 |
|--------------------|---------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Lorraine Calzetta Patrovic |
| Date prepared: | April 23, 2004 |
| Classification: | Class II (21 CFR § 878.4810 Laser Surgical Instrument for use in General
and Plastic Surgery and in Dermatology) |
| Common Name: | Dermatology Laser, Smoothbeam Laser System |
| Predicate Devices: | Candela Smoothbeam 1450 nm Diode Laser System (K013825 ,K030834) |

Description:

The Diode laser is a Continuous Wave, diode medical laser, controlled by an embedded processor, to be used I Is Doc tase is a continued of wrinkles. The Candela Smoothbeam Laser System is comprised of a power supply, optical delivery system, software control system and Dynamic Cooling Device. The laser output power supply, optical defreery of claring cosmation of the produces circular beams on the skin. The Dynamic Clooling Device, provides a short burst of cryogen spray during the laser treatment. The cryogen is delivered via a hose to a nozzle located in the handpiece. The Dynamic Cooling Device functions to cool the skin during the a hose to a nozine risunizing thermal damage to skin during laser treatment and reducing pain associated with laser treatment.

The Candela Smoothbeam Laser System is equipped with safety interlock systems to protect patients and operations. IJsers of the device, make selections from a control panel to regulate operation during the laser treatment.

Testing:

As a laser product, the Smoothbeam Laser System is required to conform and does conform to the Laser Performance Standard (21 CFR 1040). In addition, the device will conform to the UL 2601 Electrical Safety Standard and with the Harmonized Standard EN 60601-1-2, Part 2 established by the European Community.

Safety and Effectiveness Information:

The modality of action for the treatment of sebaceous hyperplasia is similar to that of previously cleared indications in the treatment of back acne and the treatment of inflammatory acne vulgaris. Published clinical data, using t he predicate Smoothbeam Laser, cleared for use in the market, produced results that demonstrate that the Smoothbeam Laser is safe and effective for the expanded indication, - the treatment of sebaceous hyperplasia

Summary of Substantial Equivalence:

The Candela Smoothbeam Laser System described in this submission is identical to the currently marketed Candela Smoothbeam Laser System based on operating principles, materials, mechanism of action, design, construction and intended use. Candela believes that the Smoothbeam Laser is substantially equivalent to the predicate device.

Image /page/0/Picture/14 description: The image shows the characters 'C', a colon, and the number '1'. The characters are written in a simple, slightly rough font. The colon is positioned between the 'C' and the '1', indicating a possible label or ratio.

1

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring a symbol that resembles a bird or a stylized human figure with outstretched arms. The emblem is composed of three curved lines that create a sense of movement and dynamism.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV 2 2 2004

Ms. Lorraine Calzetta Patrovic Manager, Regulatory Affairs Candela Corporation 530 Boston Port Road Wayland, Massachusetts 01778-1886

Re: K041242

Trade/Device Name: Candela Smoothbeam Laser System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: August 24, 2004 Received: August 26, 2004

Dear Ms. Patrovic:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 10 rate exaction to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

2

This letter will allow you to begin marketing your device as described in your Section 510(k) rms reter notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

R. Mark A. Millmann

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Indications for Use

510(k) Number (if known):

Device Name: Candela Smoothbeam Laser ( aka Candela MID IR Laser)

Indications For Use:

The Candela Smoothbeam Laser is indicated for the following uses :

For use in dermatology: incision, excision, ablation, and vaporization with hemostasis of soft tissue,

Treatment of back acne

Treatment of atrophic acne scars

Treatment of facial wrinkles

Treatment of mild to moderate acne vulgaris

New indication : Treatment of Sebaceous Hyperplasia

Prescription Use _X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Mark N. Mellem

Page 1 of 1

Division of General, Restorative, and Neurological Devices

510(k) Number K041242

02:3